Announced Fri, 26 Jun · 16:11 IST
Board meeting on Aug 6, 2026 to approve Q1 FY27 results
Results View source PDF
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.3%1-day move
₹6240.00
prior close
₹6254.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—-0.4-0.6+0.2+1.3+2.2+3.6+1.9+1.7+0.3+9.5———
Up moveDown movePending
AI summary
Procter & Gamble Health has informed BSE that its Board of Directors will meet on Thursday, August 6, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. This is a routine intimation under SEBI Listing Regulations, with no other agenda items disclosed.
Likely market impact
Routine advance notice; investors should watch for the Q1 FY27 earnings release following the meeting for revenue and margin trends.